Losartan, an AT1 receptor antagonist, reduced TAAs in this mouse model with Marfan syndrome [41], whereas AT2 receptor deficiency augmented aortic expansion in this mouse model [42]. This evidence concerns the gene AGTR2 and Marfan syndrome.